Contraline Inc. is a pioneering venture-backed medical device company based in Charlottesville, Virginia, dedicated to revolutionizing male contraceptive technologies. The company’s flagship innovation, ADAM™, stands out as the world's first implantable hydrogel that offers a long-lasting, non-hormonal, and reversible contraception solution for men. By harnessing its proprietary hydrogel platform, Contraline aims to address pressing global reproductive health challenges and cater to areas with significant unmet needs, ultimately providing effective and innovative solutions that can change lives. With a strong focus on advancing male reproductive health, Contraline is positioned at the forefront of a transformative industry.